相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The variable phenotype and low-risk nature of RAS-positive thyroid nodules
Marco Medici et al.
BMC MEDICINE (2015)
Papillary thyroid carcinoma and multiple endocrine neoplasia type 2
B. Febrero et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
Raffaele Ciampi et al.
THYROID (2013)
Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
Cristina Romei et al.
THYROID (2012)
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer
B. Cosci et al.
ENDOCRINE-RELATED CANCER (2011)
High Prevalence of RAS Mutations in RET-Negative Sporadic Medullary Thyroid Carcinomas
Margarida M. Moura et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Molecular genetics and diagnosis of thyroid cancer
Yuri E. Nikiforov et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation
Alexander L. Shifrin et al.
SURGERY (2010)
Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism
M. Rotondi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C?
Alexander L. Shifrin et al.
SURGERY (2009)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper et al.
THYROID (2009)
Routine serum calcitonin measurement in the evaluation of thyroid nodules
Rossella Elisei
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer
Cristina Romei et al.
ENDOCRINE-RELATED CANCER (2008)
Medullary thyroid cancer: therapeutic targets and molecular markers
Douglas W. Ball
CURRENT OPINION IN ONCOLOGY (2007)
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods
E Mathe et al.
NUCLEIC ACIDS RESEARCH (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Handling of thyroid follicular patterned lesions
J Rosai
ENDOCRINE PATHOLOGY (2005)
Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature
S Rossi et al.
ENDOCRINE-RELATED CANCER (2005)
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior
RP Biscolla et al.
THYROID (2004)
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition
R Elisei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation
M Brauckhoff et al.
THYROID (2002)
Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer
L Fugazzola et al.
CLINICAL ENDOCRINOLOGY (2002)
Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: An unusual clinical coexistence
G Mazziotti et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2001)
Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice
DS Acton et al.
ONCOGENE (2000)
RET proto-oncogene mutations in thyroid carcinomas: Clinical relevance
F Pacini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2000)